AgingResearch.NewsJoin free

ABBV-0805

Intervention

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • 1 of 1 finding with company ties
  • Animals1

Outcomes

1

Neurotoxicity

downin cells1

1 study

  1. ABBV-0805 decreases neurotoxicity in cells.

    “inhibition of neurotoxicity in primary neurons”

    Cells

    ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease

    Neurobiology of disease1 Nov 2021

Latest

Related